1/ As part of Week 3 of our #CRCAwarenessMonth campaign, we present our second of two ”Q&A with an Expert” sessions on non-modifiable CRC risk!
⭐️Risk of CRC in Patients with IBD⭐️ with the one and only @DrSamirAShah1
( & moderator @HannahWFiske )
🧠 Scroll to learn more 👇🏽
It was a week of excitement and celebration! We are thrilled to have our three new incoming fellows Kuntal, Jillian & Jenn join @TuftsMedicalCtr as 1st year GI fellows! We wish you success in your career paths; the entire Tufts GI Division looks forward to working with you soon!
1/ ⏰ for #EBGI Tweetorial🧵w/@Chatterjee_MD & @Bengnonny!
“Do Not Extend Interval Between CRC Screening Colonoscopies from 10 to 15 Years: Perils of Administrative Databases”
📜 Summary https://t.co/6cNJnShKMm
🎧 https://t.co/Z8vmQ9OcJ7
📰 https://t.co/ZoVR0KzQis
#GITwitter
1/⏰ for #EBGI Tweetorial🧵w/ @PeterBhandariMD
Long-term efficacy and safety of Ustekinumab for UC: 4 year data from the UNIFI Long-term Maintenance Study
From @RahulSDalalMD👇
📜 Summary https://t.co/brgT2JOg3Q
🎧 https://t.co/YANvP9xLWa
📰 https://t.co/awtmmTAZZN
#GITwitter
1/ ⏰ for #EBGI Tweetorial🧵w/ @nataliejowilson!
“Stemming the Tide: Is Long-Acting Octreotide Injection Better Than Standard of Care for Angiodysplasia-Related GI Bleeding?”
📜Summary https://t.co/2KgFzfQd7m
🎧Podcast https://t.co/zQpHT1Ww1k
📰Article https://t.co/zeFDbkcVFr
1/ ⏰ for #EBGI Tweetorial🧵w/ @CamilleLupianez & @SantaellaMD!
“Multi-Target Stool DNA Test for CRC Screening: How Accurate is the New Version?”
📜:https://t.co/NWs7aEl2DM
🎧:https://t.co/p22KLLOCqJ
📰: https://t.co/LqebFXgSRM
#GITwitter
1/ ⏰ for #EBGI 🧵w/ @KBhowmick92!
“Cell-free DNA Blood Test for CRC Screening: A Promising Development Won’t “Eclipse” Current Tools”
📜 - https://t.co/nti0Ynh3fX
🎧 - https://t.co/WBtYksz6zc
📰 - https://t.co/eQUNbfoqAk
#GITwitter